|
J Biol Chem, Vol. 273, Issue 21, 12973-12980, May 22, 1998
Characterization of the Gene Encoding the Human Kidd Blood
Group/Urea Transporter Protein
EVIDENCE FOR SPLICE SITE MUTATIONS IN Jknull
INDIVIDUALS*
Nicole
Lucien ,
Frédéric
Sidoux-Walter ,
Bernadette
Olivès ,
Joann
Moulds§,
Pierre-Yves
Le Pennec ,
Jean-Pierre
Cartron ¶, and
Pascal
Bailly
From INSERM U76, Institut National de la Transfusion
Sanguine, 6 rue Alexandre Cabanel, 75015 Paris, France and
§ University of Texas-Houston Medical School,
Houston, Texas 77030
 |
ABSTRACT |
The Kidd (JK) blood group is carried by an
integral membrane glycoprotein which transports urea through the red
cell membrane and is also present on endothelial cells of the vasa
recta in the kidney. The exon-intron structure of the human blood group Kidd/urea transporter gene has been determined. It is organized into 11 exons distributed over 30 kilobase pairs. The mature protein is encoded
by exons 4-11. The transcription initiation site was identified by
5'-rapid amplification of cDNA ends-polymerase chain reaction at
335 base pairs upstream of the translation start point located in exon
4. The 5'-flanking region, from nucleotide 837 to 336, contains
TATA and inverted CAAT boxes as well as GATA-1/SP1 erythroid-specific
cis-acting regulatory elements. Analysis of the
3'-untranslated region reveals that the two equally abundant erythroid
transcripts of 4.4 and 2.0 kilobase pairs arise from usage of different
alternative polyadenylation signals.
No obvious abnormality of the Kidd/urea transporter gene, including the
5'- and 3'-untranslated regions, has been detected by Southern blot
analysis of the blood of two unrelated Jknull individuals
(B.S. and L.P.), which lacks all Jk antigens and Jk proteins on red
cells, but was genotyped as homozygous for a "silent" Jkb allele. Further analysis indicated that
different splice site mutations occurred in each variant. The first
mutation affected the invariant G residue of the 3'-acceptor splice
site of intron 5 (variant B.S.), while the second mutation affected the
invariant G residue of the 5'-donor splice site of intron 7 (variant
L.P.). These mutations caused the skipping of exon 6 and 7, respectively, as seen by sequence analysis of the Jk transcripts
present in reticulocytes. Expression studies in Xenopus
oocytes demonstrated that the truncated proteins encoded by the spliced
transcripts did not mediate a facilitated urea transport compared with
the wild type Kidd/urea transporter protein and were not expressed on
the oocyte's plasma membrane. These findings provide a rational explanation for the lack of Kidd/urea transporter protein and defect in
urea transport of Jknull cells.
 |
INTRODUCTION |
The Kidd blood group system (JK) is defined by two
codominant alleles, Jka and Jkb,
of similar frequency (0.51 and 0.49, respectively) in the Caucasian population, but showing large differences in other ethnic groups (1,
2). Alloantibodies against the Jk antigens may occasionally be involved
in severe transfusion incompatibilities and newborn hemolytic disease.
There are three common phenotypes Jk(a+b ), Jk(a b+), and Jk(a+b+)
and a rare null phenotype, Jk(a b ), first described by Pinkerton
et al. (3), also called Jknull. The frequency of
this phenotype is increased in certain populations (Asian, Polynesian,
or Indian extraction). The Jknull phenotype results from
two different genetic backgrounds: (i) homozygous inheritance of a
"silent" allele Jk at the JK locus and (ii)
inheritance of a dominant inhibitor gene In(Jk), unlinked to
the JK locus (1, 2). Following immunization by transfusion
or pregnancy, Jknull individuals may produce an antibody
called anti-Jk3 (or anti-Jkab), which reacts
with all common red cells carrying the Jka and/or
Jkb antigens, but is unreactive with Jknull
cells themselves.
The discovery that red cells from Jknull individuals
exhibited an increased resistance to lysis in aqueous 2 M
urea (4) led to the suspicion that the Jk antigens might be related to the urea transporter of the human erythrocytes (for a review, see
Moulds (5)). This prediction was fully confirmed by molecular cloning
of the human erythroid urea transporter (clone HUT11) (6), by
cross-hybridization with a rabbit cDNA transporter (7), and the
demonstration that the HUT11 urea transporter and the Kidd blood group
are carried by the same protein (8). This is based on the following
findings: (i) in coupled transcription-translation assays, the HUT11
cDNA directed the synthesis of a 36-kDa protein, which was
immunoprecipitated by a human anti-Jk3 antibody; (ii) the
anti-Jk3 immunoprecipitated also a protein material of
similar mass from all red cell membranes (after N-glycanase
treatment), except those from Jknull cells; (iii) a rabbit
antibody against the HUT11-protein reacted on immunoblots with all
human erythrocytes except those from Jknull; and (iv) the
structural gene encoding HUT11 was assigned to chromosome 18q12-q21 by
in situ hybridization, like the Kidd blood group locus. More
recently, the Kidd blood group Jka/Jkb
polymorphism (D280N) was determined and used to demonstrate its lack of
association with type 1 diabetes mellitus (9).
The Kidd/HUT11 polypeptide is expressed on human red cells as well as
on the endothelial cells of vasa recta in the inner and outer medulla
of the kidney (10, 11). Rapid urea transport may help to preserve the
osmotic stability and deformability of the red cells and to stabilize
osmotic gradients in the renal medulla (12, 13). In the kidney, this
transport system contributes to the urinary concentrating mechanism
(14, 15) involved in water preservation. Recently, a new urea
transporter specific for the human kidney (clone HUT2) was cloned (16)
and functionally compared with the erythroid transporter (17). These
transporters are analogous to those found in other species, and their
characterization, probably as a new family of transporters, will
contribute to the clarification of their critical role in the renal
water conservation mechanism (see Hediger et al. (18) for
review) (19, 20). In this report we have further characterized the gene
encoding the erythroid Kidd/HUT11 polypeptide, and we have analyzed the molecular basis of the Jknull phenotype from two unrelated
individuals.
 |
MATERIALS AND METHODS |
Blood Samples and Reagents--
Blood samples from individuals
of common Jk phenotypes came from the Institut National de la
Transfusion Sanguine (Paris, France). Two Jknull blood
samples were investigated; donor L.P. was from the Center National de
Référence sur les Groupes Sanguins in Paris, and donor B.S.
was from the Irwin Memorial Blood Center (San Francisco, CA).
Restriction endonucleases, modifying enzymes, pUC vectors, and
N-glycosidase F (PNGase-F purified from Flavobacterium meningosepticum) came from New England Biolabs (UK). Radiolabeled nucleotides, [14C]urea (1.96 GBq/mmol), and
[3H]raffinose (188.7 GBq/mmol) were purchased from
Amersham (Bucks, UK). Expand High Fidelity and Expand Long Template
PCR1 systems from Boehringer
Mannheim (Germany) were used for PCR amplification. Nucleotide
sequences were determined on both strands by the dideoxy chain
termination method (Sanger) with Sequenase version 2.0 (U. S
Biochemical Corp., Cleveland, OH) or with ThermoSequenase fluorescent
labeled primer cycle sequencing kit from Amersham (Bucks, UK) using
5'(Cy5)-primers (Genset, France).
Isolation of Human JK Gene--
Approximately 2.5 × 106 phages from a human leukocyte genomic library
constructed in EMBL3 Sp6/T7 (CLONTECH Laboratories,
Inc., Palo Alto, CA) were plated and hybridized under standard
procedures with a 32P-labeled full-length HUT11 cDNA
probe (1-1528) using the random primed DNA labeling kit (Boehringer
Mannheim, Germany). The positive clones were initially mapped by
SacI digestion followed by Southern blot hybridization using
HUT11 and the 5'-end region (see below) as probes. The positive
individual gene fragments were subcloned into pUC vector and sequenced.
The exons, identified from the HUT11 cDNA sequence, and their
flanking regions, were fully sequenced as were some short introns. The
introns were sized by PCR using primers from flanking regions of the
intron. At least, all sizes were confirmed by PCR using human genomic
DNA as template and Expand Long Template PCR system.
5'- and 3'-End Region Determination by cDNA Cloning--
The
5'-UT sequence was cloned by 5'-rapid amplification of the cDNA
ends (RACE) (16), using the human fetal liver 5'-RACE Ready cDNA
kit with Advantage KlenTaq Polymerase Mix
(CLONTECH). Briefly, a hemi-nested PCR
amplification under stringent conditions (94 °C for 45 s,
60 °C for 45 s, 72 °C for 1 min, for 30 cycles) was carried
out between the primer complementary to 5'-end anchor and two antisense
primers from the 5'-coding sequence of HUT11 cDNA, AS-1 (antisense
primer, position 109-86) and AS-2 (antisense primer, position 44-21).
After agarose gel analysis, transfer, and Southern blot hybridization
using 32P-labeled probe Pr.2* (nt 194 to 174),
5'-CTACCTAAAATAAAGATTATA-3', deduced from the 5'-end of an unpublished
human bone marrow cDNA clone, the positive bands were subcloned and
sequenced. Similarly, the 3'-UT sequence was amplified using human bone
marrow Marathon-Ready cDNA (CLONTECH) between
the primers complementary to 3'-end adaptor and two sense primers from
the 3'-coding sequence of HUT11 cDNA, SP-1 (sense primer, position
1219-1242) and SP-2 (sense primer, position 1304-1327. For primer
designation, nt +1 was taken as the first nucleotide of the HUT11
initiation codon (6).
Northern Blot Analysis--
Poly(A+) RNA from human
fetal liver (CLONTECH) or total RNAs isolated from
six injected oocytes according to Chomczynski and Sacchi (21), were
resolved by electrophoresis on 6% (w/v) formaldehyde, 1% (w/v)
agarose gel, and transferred to nylon filters (Zeta-probe GT, Bio-Rad).
Hybridization with 32P-labeled probes was carried at
65 °C in 0.25 M Na2HPO4, 7%
(w/v) SDS. Stringent washes were performed in 0.02 M
Na2HPO4, 1% (w/v) SDS at 65 °C for 30 min
and exposed to Biomax-MR film with intensifying screens at
80 °C.
Southern Blot Analysis--
Total genomic DNA from B lymphoid
cell lines (Epstein-Barr virus-transformed) or from leukocytes was
digested with SacI restriction enzyme according to the
supplier (10 units/µg of DNA), resolved by electrophoresis in 0.8%
(w/v) agarose gel and transferred to a nylon membrane (Hybond
N+, Amersham, UK). The blot was prehybridized in 0.25 M Na2HPO4 (pH 7.2), 7% SDS for 5 min at 65 °C and then hybridized using a full-length
32P-labeled cDNA probe (exon 1-5' to end exon 11) in
the same buffer. Hybridization was carried out overnight at 65 °C,
and the last washing was in 0.02 M
Na2HPO4 (pH 7.2), 3% SDS for 20 min at
65 °C.
Amplification by Reverse Transcription-PCR of Jk
cDNAs--
Five micrograms of total reticulocyte RNA extracted by
the acid-phenol-ammonium method (22) were used to produce the first cDNA strands using the first strand cDNA synthesis kit
(Pharmacia, Uppsala, Sweden). One sixth of the cDNA products was
used to perform a hemi-nested PCR (94 °C for 30 s, 60 °C for
30 s, 72 °C for 1 min 15 s, for 30 cycles) in a first step
between primers SP-A (sense primer, position 21 to 1) and AS-B
(antisense primer, position 1260-1237). The second PCR was performed
with 1/25 of the first PCR products in the same conditions, using
primers SP-A and AS-C (antisense primer, position 1234-1211). Final
PCR products were identified by Southern blot analysis, subcloned, and
sequenced on both strands, using an automated Alf-Express sequencer
(Pharmacia, Uppsala, Sweden).
Analysis of Splice Sites--
Direct PCR amplification was
carried on genomic DNA (100 ng) under stringent conditions (94 °C
for 30 s, 60 °C for 30 s, 72 °C for 30 s, for 30 cycles) between primers designed from intronic sequences flanking each
exon. The PCR products were subcloned and sequenced. To avoid PCR
artifacts, sequencing was performed on both strands using independent
PCR reactions.
Transcription-Translation and Immunoprecipitation
Assays--
Full-length (Jk+) and spliceoforms
(Jk ( 6) and Jk ( 7)) cDNAs were
subcloned into the EcoRV-digested pT7TS plasmid (kindly
provided by P. Krieg, Austin, TX) and placed under the control of the
T7 promoter. The corresponding proteins were synthesized in
vitro in the transcription-translation coupled reticulocyte lysate
kit from Promega (Madison, WI) in the presence of
L-[35S]methionine (1.85 Gbq/mmol, Amersham,
Bucks, UK) and immunoprecipitated with the human anti-Jk3
antiserum obtained from an immunized Jk(a b ) individual and with an
affinity-purified polyclonal antibody raised against the N-terminal
region (residues 8-22) of the Kidd/urea transporter polypeptide
(anti-HUT11), as described previously (8). The immunoprecipitates were
analyzed by SDS-polyacrylamide gel electrophoresis (15% separating
gel) on a discontinuous buffer system (23), followed by enlightening
treatment (NEN Life Science Products) and autoradiography.
Oocyte Urea Flux Measurements and Immunoblotting
Analysis--
After linearization of the pT7TS-cDNA constructs
with SmaI restriction enzymes, capped sense RNAs were
synthesized using T7 RNA polymerase from the mCAP mRNA capping kit
(Stratagene, La Jolla, CA). Expression studies were carried out by
microinjection of cRNAs (40 ng/oocyte) in collagenase-treated
Xenopus oocytes (24) and functional tests were realized 3 days after injection as described previously (6). To determine the
expression of Jk+, Jk ( 6), and
Jk ( 7) isoforms, fractions enriched for oocyte plasma
membranes were prepared from 25 oocytes, as described by Wall and Patel (25). N-Glycosidase F treatments were performed according to the manufacturer, and a control reaction was carried out in enzyme-free buffer in otherwise identical conditions. Untreated and
N-glycosidase F-treated plasma membranes, equivalent to six
oocytes, were separated by SDS-polyacrylamide gel electrophoresis,
transferred to nitrocellulose membranes, and incubated with the
affinity-purified antibody anti-HUT11 (2 µg/ml). Specifically bound
antibodies were detected with affinity-purified goat anti-rabbit IgG
conjugated to horseradish peroxidase (Sigma) (1:15,000 dilution) and
using Luminol/Enhancer (Pierce) according to the manufacturer's
protocole.
 |
RESULTS |
Structure of the JK Gene--
Of the seven positive clones
isolated from partially Sau3A-digested human leukocyte
genomic DNA library, three Jk2, Jk10, and Jk12 were used to
characterize the exon organization and to define the intron/exon
junction sequences (Fig. 1).
SacI restriction mapping was established by Southern blot
hybridization with the HUT11 cDNA and the 5'- and 3'-end regions
(see below) as probes. Sequence analysis of the SacI
fragments from the three genomic clones revealed that the human
JK gene was composed of 11 exons distributed over 30 kb of
DNA (Fig. 1A). The exon sizes ranged from 50 bp (exon 10) to
551 bp (refer to the first used polyadenylation signal). The three
first exons include the 5'-UT part of the gene (see below) and the
remaining eight exons the open reading frame. The translation
initiation codon was located in exon 4 and the stop codon in exon 11. Thus, exons 4-11 corresponded to amino acids 1-50, 51-113, 114-156,
157-221, 222-270, 271-315, 316-332, and 333-389, respectively
(Fig. 1B). The intron sizes determined by PCR, ranged from
0.6 kb to approximately 8.6 kb. After partial sequence of the introns,
all exon/intron junctions were found to contain the canonical 5'-donor
gt and the 3'-acceptor ag sequences (Fig.
1B). Each class of intron-exon boundary was found in the JK gene. When all exons were sequenced and compared with the
published HUT11 cDNA isolated from a human bone marrow library, two
differences, one amino acid change (K44E) and one dipeptide deletion
were noted in exon 4 and 8, respectively. These changes correspond to
nonallelic differences previously reported between HUT11 and the
Jka/Jkb alleles (9).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 1.
Restriction map and intron-exon organization
of the blood group Kidd locus. A, the structure of the
Kidd (JK) gene was established by analysis of the Jk2,
Jk10, and Jk12 genomic clones and from 5'-end determination (see
text). The hatched area in the Jk12 clone lines refers to
a deletion. Exons are indicated by rectangles. Filled
symbols correspond to 5'- and 3'-UT sequences and open
symbols to coding sequences. SacI (S)
restriction sites are shown. B, exon and immediate intron
flanking splice junction sequences are indicated in capital
and small letters, respectively. The 5'-donor gt
and the 3'-acceptor ag are underlined. #Position
+1 refers to the first nucleotide of the transcription initiation site.
*The size of exon 11 refers to the first used polyadenylation signal.
The coding sequence has been submitted to the
GenBankTM/EMBL Data Bank with accession no. L36121.
|
|
Characterization of the 5'-End of the Jk Transcript--
The
5'-end of the Jk transcript was cloned by a modified rapid
amplification of cDNA ends technique, using a fetal liver cDNA as matrix, and hemi-nested PCR between the 5'-end anchor (sens primer,
49 bp) and the AS-1 and AS-2 antisense primers (see "Materials and
Methods"). When the amplification products were analyzed by Southern
blot hybridization with the probe Pr.2* (nt 194 to 174), two bands
of ~270 and ~430 bp were detected, indicating the presence of an
alternative splicing event (Fig. 2).
These bands, which corresponded to the first ~220 and ~380 bp,
respectively, at the 5' end of the primer AS-2 (after deduction of the
49 bp from the 5'-anchor primer), were subcloned, and five independent
clones were sequenced. The results indicated that the ~430-bp
fragment included the full- length transcript and located the
transcription initiation site at 335 nt upstream from the translation
initiation codon (Fig. 2). The ~270-bp fragment, however, which was
generated by alternative splicing lacked 157 nt corresponding to exon 3 (Fig. 2). This was confirmed by Southern blot with an exon 3-specific probe which hybridized with the ~430-bp but not the ~270-bp
fragments (not shown). All of this information was used to deduce the
structure organization of the three first exons of the JK
gene described above. Further studies (reverse transcription-PCR) of
the transcripts isolated from normal human reticulocytes indicated the
presence of alternatively spliced transcripts lacking sequences encoded by exons 8 and 9, and exons 7-9 (data not shown).

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 2.
Proximal promoter and 5'-UT sequences of the
Kidd/urea transporter gene. Top, nucleotide sequence of the
5'-flanking region where potential binding sites for GATA-1, SP-1,
AP-2, AP-3, Ets-1, and NF-ATp factors are shown (underlined
boldface). TATA and inverted CAAT boxes are also shown. The
transcription initiation sites (vertical arrowheads) were
identified by 5'-RACE-PCR using human fetal liver 5'-RACE-Ready
cDNA and two specific antisense primers AS-1 and AS-2 located in
exon 4. Nucleotide positions (left) are relative to the
translation initiation site located in exon 4. Below,
schematic diagram shows the four first exons of the JK gene
and the 5' region of the transcripts found in JK+
individuals. Right, Southern analysis of the 5'-UT cDNAs
obtained by 5'-RACE-PCR (see above) detected with probe Pr.2* (nt 194
to 174) located in exon 2. Scale in base pair (bp).
|
|
Next, 500 bp upstream of the erythroid transcription initiation site
from the Jk2 genomic clone was sequenced and analyzed to identify
putative cis-acting regulatory elements. This region (nt
837 to 336) contains the consensus motifs AP-3, NF-ATp, and GATA-1
in reverse orientation at position 529/ 522, 586/ 581, and
806/ 801, respectively. Sequence deviating by one nucleotide from
the consensus motifs Ets-1, AP-2, reverse Ets-1, CTCF, and a reverse
SP-1 were identified between positions 587 and 794 (Fig. 2). A
typical TATA box was also present at nt 362/ 358, which is in the
expected range of 25 to 30 nucleotides upstream of the erythroid
transcription initiation site (nt 335). Although two inverted CAAT
boxes (ATTG) were identified at nt 95 and 220, only the closest of
transcription initiation site might be functional.
Characterization of the 3'-UT Region of the Jk
Transcripts--
The transcription start site of the JK
gene is short (335 bp upstream of the translation initiation site) and
cannot account for the size difference between the two major
transcripts (~2.0 and ~4.4 kb) detected in erythroid tissues by
Northern blot (16). Therefore, we examined whether these differences
arose from the 3' end of the Jk transcripts. At first, two unconsensus
polyadenylation signals (AATTAAA and TATAAA) and four consensus sites
(AATAAA) have been located by sequence analysis of 3'-RACE-PCR
amplifications performed with reticulocyte transcripts (see
"Materials and Methods") and by sequence analysis of the 3'-end
from the Jk12 genomic clone (Fig. 3).
Then, Northern blot analysis using the HUT11 probe as well as probes
p1, p2, and p3 located in the 3'-UT region of the JK gene
clearly indicated that the two erythroid transcripts of 4.4 and 2.0 kb
arose from differential usage of two distinct polyadenylation signals
which are separated by 2.0 kb. Indeed, the HUT11 probe located 5' to
the proximal signal AATTAAA hybridized both with the 4.4- and 2.2-kb
transcripts, while probes p1, p2, and p3, located downstream this
signal hybridize only with the 4.0-kb species (Fig. 3). The colinearity
of the full 3'-end region (exon 11) was confirmed by hemi-nested
reverse transcription-PCR and hybridization of the 2.7-kb reaction
product with the HUT11 probe (see Fig. 3).

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 3.
Analysis of 3'-UT region of the Kidd/urea
transporter gene. Partial gene map showing the 3'-UT region
encoded by exon 11 and the location of potential polyadenylation
signals. The 2.7 kb were obtained by hemi-nested PCR with primers p4
(exon 11), p5, and p6 (3' end). Horizontal arrows localize
the HUT11 cDNA and the PCR primers used to prepare probes p1, p2,
and p3, which were hybridized to the Northern blots shown below.
Poly(A+) RNA (2 µg/lane) from human fetal liver was
separated by agarose gel electrophoresis and hybridized with the
indicated 32P-labeled PCR probes as described under
"Materials and Methods." Autoradiography was for 16 h at
80 °C. Size markers (kb) are indicated on the left.
Southern blot of the full 3'-end reverse transcription-PCR product
detected with the HUT11 probe is shown on the right.
|
|
The JK Gene Is Not Rearranged in Jknull Cells--
In
preliminary investigations, we confirmed by Western blot analysis with
the affinity-purified anti-HUT11 antibody (nonglycosylation dependent) (10), that the Jknull cells under study
(B.S. and L.P.) lack the Jk erythrocyte membrane protein (45-69 kDa),
as seen in Fig. 4A, as well as
the Jka and Jkb antigens (data not shown).
Next, we demonstrated by Southern blot hybridization of genomic DNA an
identical SacI digestion pattern of the Jknull
samples as compared with common Jk(a+b ) and Jk(a b+) phenotypes
(Fig. 4B), indicating that a gross rearrangement of
JK gene did not occur in these variants. The five detected bands (ranging from 2 to 7 kb) are fully concordant with the known restriction sites in the JK gene (see Fig. 1) and altogether
contain all 11 exons (Fig. 4A). Moreover, restriction
analysis with a number of other enzymes showed a simple pattern
consistent with a single copy gene (data not shown). Further analysis
by DNA genotyping (9) indicated that both Jknull
individuals were homozygous for a silent Jkb allele
(data not shown).

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 4.
Identification of splice site mutations in
two unrelated Jknull individuals. A, immunoblot
analysis of the Kidd/urea transporter protein in erythrocyte membranes
from two Jknull individuals (B.S. and L.P.) compared with
normal Jk+ controls with the Jk(a+b+), Jk(a+b ) and
Jk(a b+) phenotypes. Red cell membranes (60 µg) were separated by
SDS-polyacrylamide gel electrophoresis, transferred to a nitrocellulose
membrane, and incubated with a rabbit antibody (1:400 dilution in
phosphate-buffered saline) directed against the N-ter of the Kidd/urea
transporter HUT11 protein (10). Bound antibodies were detected with
alkaline phosphatase-labeled goat anti-rabbit IgG (diluted 1:800)
followed by revelation with the alkaline-phosphatase conjugate
substrate kit (Bio-Rad). Size of markers (kDa) are indicated by
arrows on the right. B, Southern blot analysis of
the Kidd (JK) locus in Jknull individuals (B.S.
and L.P.) compared with normal control subjects (Jk(a+b ) and
Jk(a b+) phenotypes). Genomic DNAs (15 µg/lane) were digested with
SacI restriction enzyme, subjected to electrophoresis, and
hybridized with the full-length Kidd/HUT11 cDNA probe (exon 1 to
5'-end exon 11). The sizes of DNA markers (HindIII-digested
lambda phage, kb) and exons present in each fragments are given in the
left and right margins, respectively.
C and D, dideoxy cycle sequencing of 5'-intron
exon 6 boundaries in B.S. and 3'-intron exon 7 boundaries in variant
L.P. The sample from a Jk+ individual is used as a control.
Exons are boxed and intronic sequences are shown in
lowercase letters. The point mutations are indicated by
arrows.
|
|
Molecular Analysis of the Jknull Mutations--
To
determine the molecular basis of the Jknull phenotypes,
total reticulocyte RNA from donors B.S. and L.P. were prepared and used
to amplify full-length Jk transcripts. Three amplification products of
different size (not shown) were obtained from the B.S. sample, and
several independent clones of each size were sequenced. We identified
spliceoforms that resulted from the alternative splicing of exon 6 (Jk ( 6)), exons 6, 8, and 9 (Jk ( 6, 8, and 9)) and exons 6-9 (Jk ( 6-9)). The nucleotide
sequence of the 5/7 exon junction found in the Jk ( 6)
transcript is shown in Fig. 5. All of
these spliced transcripts corresponded to the spliceoforms found in
normal Jk+ individuals (see above), which in addition, all
lacked exon 6 sequences. The Jk ( 6) clone carried the
nt 838A polymorphism typical of the Jkb allele (9),
which confirmed the results from the DNA genotyping (see above). No
other alteration of the nucleotide sequence was detected. Since exon 6 was missing in all transcripts, the intron/exon junctions surrounding
this exon were analyzed on the genomic DNA prepared from donor B.S. We
found that the skipping of exon 6 was most likely caused by a G A
transition that affected the invariant G residue of the 3'-acceptor
splice site of intron 5 (Fig. 4C). The transcripts from B.S.
potentially encode truncated polypeptides; the predicted
Jk ( 6) polypeptide would lack amino acid residues
114-156 (encoded by exon 6) of the third and fourth transmembrane
domains of the Kidd/urea transporter. The other spliceoforms
(Jk ( 6, 8, and 9) and Jk ( 6-9)) would
encode much smaller peptides with a new C-terminal extension generated
by a frameshift and premature termination.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 5.
Partial sequences of PCR-products from
Jk+ and Jk transcripts. Nucleotide
sequence of the Jk transcripts isolated from a control donor
(Jk+) and from Jknull individuals in the
regions of exon/intron junctions 5/6, 6/7, and 7/8. The display of the
sequence diagram is from the Alf-Express DNA sequencer. Top,
5/6, 6/7, and 7/8 exon junctions found in normal Jk+
individuals (control). Below, the 5/7 exon
junction found in the Jk ( 6) spliceoform from
Jknull B.S. and the 6/8 exon junction found in the
Jk ( 7) spliceoform from Jknull L.P.
|
|
Examination of the second Jknull sample (L.P.) revealed the
presence of Jkb transcripts lacking exon 7 sequences
(Jk ( 7) and Jk ( 7, 8, and 9)). The
nucleotide sequence of the 6/8 exon junction found in the
Jk ( 7) spliceoform is shown in Fig. 5. Further studies
of the genomic DNA indicated that the skipping of exon 7 was most
likely caused by a G T transversion that affected the invariant G
residue of the 5'-donor splice site of intron 7 (Fig. 4D).
The protein isoform encoded by the Jk ( 7) transcript
would lack amino acids 157-221 and include new C-ter residues
generated by a frameshift and premature termination. In all instances,
the protein isoforms potentially encoded by the spliced transcripts
identified in B.S and L.P. were not detected on red cells by Western
blot analysis with the anti-HUT11 antibody (see above).
Expression and Functional Analysis of Jk ( 6) and
Jk ( 7) Protein Isoforms--
To understand why
Jknull red cells lack Jk polypeptides and exhibit a
defective urea transport activity, we examined whether the
Jk ( 6) and Jk ( 7) transcripts
characteristic of these cells could be expressed in vitro
and in vivo.
In the cell-free transcription-translation coupled system, the plasmids
pT7TS-Jk+, -Jk ( 6), and
-Jk ( 7) directed the synthesis of 36-, 31-, and 17-kDa
protein bands, respectively, which were immunoprecipitated with the
affinity-purified anti-HUT11 antibody and with the human
anti-Jk3 antibody (Fig. 6).
No radioactive material in these regions could be immunoprecipitated
from transcription-translation of the luciferase peptide control
vector.

View larger version (84K):
[in this window]
[in a new window]
|
Fig. 6.
Expression studies in
transcription-translation-coupled reticulocyte lysate system.
Autoradiogram of L-[35S]methionine-labeled
proteins immunoprecipitated with the human anti-Jk3 and
with the affinity purified rabbit antibody raised against the N-ter of
the Kidd/urea transporter protein (HUT11) and analyzed by
SDS-polyacrylamide gel electrophoresis. Lanes 1 and
5, immunoprecipitates from pT7TS-Jk+;
lanes 2 and 6, immunoprecipitates from
pT7TS-Jk ( 6); lanes 3 and 7,
immunoprecipitates from pT7TS-Jk ( 7); lanes
4 and 8, immunoprecipitates from luciferase control
(Ctrl). Band intensity is proportional to the number of
L-[35S]methionine/polypeptide (the
Jk+, Jk ( 6), and Jk ( 7)
contain 20, 17, and 8 methionines, respectively). Arrows on
the left refer to product size (kDa).
|
|
To test whether these Jk ( 6) and Jk ( 7)
proteins were expressed as functional urea transporters, cRNA
transcripts were synthesized and injected into Xenopus
oocytes. Three days later, we found that the [14C]urea
uptake of Jk ( 6) and Jk ( 7)
cRNA-injected oocytes was not different from that of water-injected control oocytes, whereas the [14C]urea uptake of
Jk+ cRNA-injected oocytes reached 38 pmol/oocyte after 3 min (Fig. 7A). Northern blot
analysis also revealed that all cRNA injected oocytes showed a stable
specific signal between day 0 and 3 after injection (see Fig.
7B). Protein expression in oocyte plasma membranes was also
analyzed by Western blot analysis with the affinity-purified anti-HUT11
antibody.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 7.
Expression and functional analysis of Jk
proteins in Xenopus oocytes. A, time course of
[14C]urea uptake in oocytes. The assay was initiated by
suspending individual oocytes in 0.2 ml of Barth's solution containing
1 mM urea, 2 µCi/ml [14C]urea, and 10 µCi/ml [3H]raffinose. The urea uptake was stopped after
the indicated time (t = 1.5, 3, and 6 min) by addition
of 3 ml of ice-cold Barth's solution and followed by two rapid washes
with 5 ml of the same solution. Then, the oocyte-associated
14C radioactivity was determined as described previously
(6). Six individual oocytes were counted for each incubation. Mean and
S.E. from two different experiments are shown. B, Northern
blot analysis of cRNA encoding Jk+, Jk ( 6),
and Jk ( 7) in oocytes. Total oocyte RNAs (15 µg/lane)
at the day of injection and 3 days after were separated and hybridized
with the 32P-labeled HUT11 cDNA probe, as described
under "Materials and Methods." Equal loading and absence of
degradation were checked by staining with ethidium bromide.
Autoradiography was for 1 h at 80 °C. C,
immunoblot analysis of fraction enriched for plasma membranes of
oocytes prepared 3 days after injection of water (control) or cRNA
encoding for Jk+, Jk ( 6) and
Jk ( 7). Untreated and N-glycosidase
F-treated plasma membranes equivalent of six oocytes were analyzed by
SDS-polyacrylamide gel electrophoresis and immunoblotted with the
rabbit antibody against the N-ter of the Kidd/urea transport protein
HU11, as described in Materials and Methods. Red cell membranes from a
Jk+ donor were used as control. Values on the right refer
to product size (kDa).
|
|
We found that a strongly reactive band of 46-69 kDa was present in
control oocytes expressing the functional Jk+ protein, the
size of which was reduced to 36 kDa after N-glycosidase F
treatment (Fig. 7C). However, using oocytes injected with
the Jk ( 6) and Jk ( 7) cRNAs, no signal
could be detected by Western blotting, neither in the total cell
lysates (not shown) nor in the plasma membrane fraction (Fig.
7C).
 |
DISCUSSION |
The studies reported here define the structural organization of
the JK gene which encodes the human Kidd blood group/urea transporter protein. This gene spans 30 kb of DNA and consisted of 11 exons, of which exons 4-11 contained all the coding information for
the mature protein. Exons 4-11 appear as being distributed along the
gene into two groups of two times two exons separated by a large
intronic sequence (E4, E5 and E6, E7, then E8, E9 and E10, E11),
evocative of an internal gene duplication. Indeed, this may parallel
the topology of the Jk polypeptide which can be subdivided into two
homologous hydrophobic parts, each carrying a LP box
(LPXXTXPF) encoded by exons 7 and 11, respectively, and previously reported to be an internal duplicated
signature sequence of urea transporters (26).
The erythroid transcription initiation site of the JK gene
was identified 335 bp upstream from the translation initiation site.
Examination of nucleotide sequences that are immediately upstream
revealed a typical TATA box, one inverted CAAT box at the expected
position, and several putative cis-regulatory elements that
may bind a variety of transcription factors (27), among which are those
involved in erythroid/megakaryocytic expression (28, 29). The presence
of a potential binding site for a NF-ATp factor which regulates the
inducible expression of several cytokine genes is intriguing (30, 31).
However, functional analysis will be required to determine which
elements and which factors bind to this promoter in tissues were the
Kidd/urea transporter is expressed.
We have also shown that the 4.4- and 2.0-kb erythroid Kidd/urea
transport mRNAs detected by Northern blot (16) arise from usage of
two different polyadenylation signals, indicating that the two equally
abundant transcripts encode the same 45-kDa polypeptide. This is at the
opposite to UT1 and UT2 urea transport transcripts from rat kidney (4.0 and 2.9 kb, respectively), which are alternative splice products
derived from a single gene by differential utilization of alternative
5'-exon groups (19). The rat homologue of HUT11, called UT3 (20), is
encoded by a single 3.8-kb transcript, which is translated into a
protein of 384 amino acids sharing 80% identity with HUT11. It is
possible that the first polyadenylation signal used in the human
primary transcript is absent or not used in the rat. The role of large
3'-UT sequences in some transcripts is not well understood, although
some may play a role in regulation of expression (32, 33).
We next examined blood from two rare unrelated Jknull
individuals, one Caucasian (L.P.) and another of Chinese (B.S.) origin, that lacked Jk antigens and Jk protein expression on red cells. Genomic
DNA analysis indicated that both donors were homozygotes for a
Jkb allele that exhibited no alteration of the
coding sequence. Therefore, although the JK genes were
present in these variants, they were not phenotypically expressed.
Sequence analysis of reticulocyte transcripts from B.S. and L.P.
indicated that alternatively spliced transcripts lacking at least exon
6 and exon 7, respectively, were present. Examination of exon/intron
junctions of the JK gene further revealed that B.S. and L.P.
were homozygous for point mutations at conserved 3'-acceptor
(ag aa) and 5' donor (gt tt) splice sites of introns 5 and 7, respectively. Splice
site mutations lead to exon skipping and are well known to abolish or
reduce normal splicing (see Maquat (34) and references therein). Since
the Kidd/urea transporter protein is absent from Jknull cells, it is likely that the spliced transcripts are either unstable and not translated, or the corresponding truncated proteins are misrouted. At first, we found that the Jk ( 6) and
Jk ( 7) transcripts typical of Jknull cells
could be translated into polypeptides of 31 and 17 kDa, respectively,
as seen by immunoprecipitation with specific antibodies in a cell-free
transcription-translation coupled system (Fig. 6). Next, we found that
when expressed in Xenopus oocytes these truncated proteins
did not mediate a facilitated urea transport, in contrast to the
full-length wild type Jk+ protein, although all injected
cRNAs had a similar stability on a 3 days period, as seen by Northern
blot analysis. Further analysis revealed that the plasma membrane
fraction from oocytes expressing the functional urea transporter
(encoded by the Jk+ cRNA) carried a 46-69-kDa glycoprotein
component, which could be deglycosylated into a 36-kDa protein, as
expected for the Kidd/urea transporter protein (6, 8). On the contrary,
the Jk ( 6) and Jk ( 7) polypeptides were
neither detected in total cell lysates nor in the enriched plasma
membrane fraction from the oocytes, which could be explained by a rapid
intracellular degradation. Indeed, the predicted truncated proteins are
most likely misfolded by lack the transmembrane domains 3 and 4, and
transmembrane domain 5, including the hydrophilic loop carrying the
N-glycosylation site at Asn221, respectively.
Therefore, these findings provide a rationale explanation for the lack
of Kidd/urea transporter protein and defect in urea transport of
Jknull cells.
As the Kidd/HUT11 transcript is distributed widely in various organs
(16), it is surprising that Jknull individuals who have a
urea transport deficiency (35) did not suffer a clinical syndrome,
except for a reduced capability to concentrate urine (36), as was the
unexpected finding that donors of the blood group Colton null
phenotype, who lack the water channel aquaporin-1, did not produce a
severe or lethal phenotype (37, 38). It is postulated that mechanisms
which compensate or reduplicate the function of the missing protein may
exist. This should stimulate more studies of these transporters in red
cell membranes and various organs. In addition, further investigations
of other Jknull individuals from different ethnic groups
(5), from both physological and fundamental aspects, may provide new
information for addressing these issues.
 |
ACKNOWLEDGEMENTS |
We are grateful to Phyllis S. Walker (Irwin
Memorial Center, San Francisco, CA) for the help in collecting the
B.S. blood sample and to Peter M. T Deen (University of Nijmegen, The
Netherlands) for advice in oocyte methodology.
 |
FOOTNOTES |
*
This work was supported in part by INSERM.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: INSERM U76,
Institut National de la Transfusion Sanguine, 6 rue Alexandre Cabanel, 75015 Paris, France. Tel.: (33) 1.44.49.30.00; Fax: (33) 1.43.06.50.19; E-mail: cartron{at}infobiogen.fr.
1
The abbreviations used are: PCR, polymerase
chain reaction; RACE, 5'-rapid amplification of cDNA ends; UT,
untranslated; SP, sense primer; AP, antisense primer; nt, nucleotide;
bp, base pair(s); kb, kilobase pair(s).
 |
REFERENCES |
-
Race, R. R.,
and Sange, R.
(1975)
Blood Groups in Man, 6th ed., pp. 178-260, Blackwell, Oxford
-
Daniels, G.
(1995)
Human Blood Groups, pp. 257-355, Blackwell, Oxford
-
Pinkerton, F. J.,
Mermod, L. E.,
Liles, B. A.,
Jack, J. A., Jr.,
and Noades, J.
(1959)
Vox Sang.
4,
155-160
-
Heaton, D. C.,
and McLoughlin, K.
(1982)
Transfusion
22,
70-71[CrossRef][Medline]
[Order article via Infotrieve]
-
Moulds, J. M.
(1995)
Blood Cell Biochem.
6,
267-278
-
Olivès, B.,
Neau, P.,
Bailly, P.,
Hediger, M. A.,
Rousselet, G.,
Cartron, J. P.,
and Ripoche, P.
(1994)
J. Biol. Chem.
269,
31649-31652[Abstract/Free Full Text]
-
You, G.,
Smith, C. P.,
Kanai, Y.,
Lee, W-S.,
Stelzner, M.,
and Hediger, M. A.
(1993)
Nature
365,
844-847[CrossRef][Medline]
[Order article via Infotrieve]
-
Olivès, B.,
Mattei, M-G.,
Huet, M.,
Neau, P.,
Martial, S.,
Cartron, J-P.,
and Bailly, P.
(1995)
J. Biol. Chem.
270,
15607-15610[Abstract/Free Full Text]
-
Olivès, B.,
Merriman, M.,
Bailly, P.,
Bain, S.,
Barnell, A.,
Todd, J.,
Cartron, J-P.,
and Merriman, T.
(1997)
Hum. Mol. Genet.
6,
1017-1020[Abstract/Free Full Text]
-
Xu, Y.,
Olivès, B.,
Bailly, P.,
Fischer, E.,
Ripoche, P.,
Ronco, P.,
Cartron, J-P.,
and Rondeau, E.
(1996)
Kidney Int.
51,
138-146
-
Promeneur, D.,
Rousselet, G.,
Bankir, L.,
Bailly, P.,
Cartron, J-P.,
Ripoche, P.,
and Trinh-Trang-Tran, M. M.
(1996)
J. Am. Soc. Nephrol.
7,
852-860[Abstract]
-
Macey, R. I.
(1984)
Am. J. Physiol.
246,
C195-C203[Abstract/Free Full Text]
-
Macey, R. I.,
and Youssef, L. W.
(1988)
Am. J. Physiol.
254,
C669-C674[Abstract/Free Full Text]
-
Knepper, M. A.,
and Star, A.
(1990)
Am. J. Physiol.
259,
F393-F401[Abstract/Free Full Text]
-
Gillin, A. G.,
and Sands, J. M.
(1993)
Semin. Nephrol.
13,
146-154[Medline]
[Order article via Infotrieve]
-
Olivès, B.,
Martial, S.,
Mattei, M-G.,
Matassi, G.,
Rousselet, G.,
Ripoche, P.,
Cartron, J-P.,
and Bailly, P.
(1996)
FEBS Lett.
386,
156-160[CrossRef][Medline]
[Order article via Infotrieve]
-
Martial, S.,
Olivès, B.,
Abrami, L.,
Couriaud, C.,
Bailly, P.,
You, G.,
Hediger, M.,
Cartron, J-P.,
Ripoche, P.,
and Rousselet, G.
(1996)
Am. J. Physiol.
271,
F1264-F1268[Abstract/Free Full Text]
-
Hediger, M. A.,
Smith, C. P.,
You, G.,
Lee, W-S.,
Kanai, Y.,
and Shayakul, C.
(1996)
Kidney Int.
49,
1615-1623[Medline]
[Order article via Infotrieve]
-
Shayakul, C.,
Steel, A.,
and Hediger, M. A.
(1996)
J. Clin. Invest.
98,
2580-2587[Medline]
[Order article via Infotrieve]
-
Tsukaguchi, H.,
Shayakul, C.,
Berger, U. V.,
Takui, T.,
Brown, D.,
and Hediger, M. A.
(1997)
J. Clin. Invest.
99,
1506-1515[Medline]
[Order article via Infotrieve]
-
Chomczynski, P.,
and Sakaki, Y.
(1987)
Anal. Biochem.
162,
156-159[Medline]
[Order article via Infotrieve]
-
Izraeli, S.,
Ppfleiderer, C.,
and Lion, T.
(1991)
Nucleic Acids Res.
19,
6051[Free Full Text]
-
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
-
Martial, S.,
Ripoche, P.,
and Ibarra, C.
(1991)
Biochim. Biophys. Acta
1090,
86-90[Medline]
[Order article via Infotrieve]
-
Wall, D. A.,
and Patel, S.
(1989)
J. Membr. Biol.
107,
189-201[CrossRef][Medline]
[Order article via Infotrieve]
-
Rousselet, G.,
Bailly, P.,
and Ripoche, P.
(1996)
Am. J. Physiol.
270,
F554-F555[Free Full Text]
-
Faisst, S.,
and Meyer, S.
(1992)
Nucleic Acids Res
20,
3-26[Free Full Text]
-
Mignotte, V.,
Lemarchandel, V.,
and Roméo, P. H.
(1995)
Hematologie
1,
19-30
-
Orkin, S.
(1995)
J. Biol. Chem.
270,
4955-4958[Free Full Text]
-
Ahuja, S. K.,
Shetty, A.,
Tiffany, H. L.,
and Murphy, P. M.
(1994)
J. Biol. Chem.
269,
26381-26389[Abstract/Free Full Text]
-
Rao, A.
(1994)
Immunol. Today
15,
274-281[CrossRef][Medline]
[Order article via Infotrieve]
-
Rastinejad, F.,
and Blau, H. M.
(1993)
Cell
72,
903-917[CrossRef][Medline]
[Order article via Infotrieve]
-
Jackson, R. J.
(1993)
Cell
74,
9-14[CrossRef][Medline]
[Order article via Infotrieve]
-
Maquat, L. E.
(1996)
Am. J. Hum. Genet.
59,
279-286[Medline]
[Order article via Infotrieve]
-
Fröhlich, O.,
Macey, R. I.,
Edwards-Moulds, J.,
Gargus, J. J.,
and Gunn, R. B.
(1991)
Am. J. Physiol.
260,
C778-C783[Abstract/Free Full Text]
-
Sands, J. M.,
Gargus, J. J.,
Frölich, O.,
Gunn, R. B.,
and Kokko, J. P.
(1992)
J. Am. Soc. Nephrol.
2,
1689-1696[Abstract]
-
Preston, G. M.,
Smith, B.,
Zeidel, L. M.,
Moulds, J. J.,
and Agre, P.
(1994)
Science
265,
1585-1587[Abstract/Free Full Text]
-
Mathai, J. C.,
Mori, S.,
Smith, B. L,
Preston, G. M.,
Mohandas, N.,
Collins, M.,
van Zijl, P. C. M.,
Zeidel, M. L.,
and Agre, P.
(1996)
J. Biol. Chem.
271,
1309-1313[Abstract/Free Full Text]
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Uchiyama, R. Kikuchi, N. Konno, T. Wakasugi, and K. Matsuda
Localization and regulation of a facilitative urea transporter in the kidney of the red-eared slider turtle (Trachemys scripta elegans)
J. Exp. Biol.,
January 15, 2009;
212(2):
249 - 256.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Fenton and M. A. Knepper
Urea and Renal Function in the 21st Century: Insights from Knockout Mice
J. Am. Soc. Nephrol.,
March 1, 2007;
18(3):
679 - 688.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Levin, R. de la Fuente, and A. S. Verkman
Urearetics: a small molecule screen yields nanomolar potency inhibitors of urea transporter UT-B
FASEB J,
February 1, 2007;
21(2):
551 - 563.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. A. Potter, G. Stewart, and C. P. Smith
Urea flux across MDCK-mUT-A2 monolayers is acutely sensitive to AVP, cAMP, and [Ca2+]i
Am J Physiol Renal Physiol,
July 1, 2006;
291(1):
F122 - F128.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Doran, J. D. Klein, Y. H. Kim, T. D. Smith, S. D. Kozlowski, R. B. Gunn, and J. M. Sands
Tissue distribution of UT-A and UT-B mRNA and protein in rat
Am J Physiol Regulatory Integrative Comp Physiol,
May 1, 2006;
290(5):
R1446 - R1459.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Sands and D. G. Bichet
Nephrogenic Diabetes Insipidus
Ann Intern Med,
February 7, 2006;
144(3):
186 - 194.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Stewart, C. Graham, S. Cattell, T. P. L. Smith, N. L. Simmons, and C. P. Smith
UT-B is expressed in bovine rumen: potential role in ruminal urea transport
Am J Physiol Regulatory Integrative Comp Physiol,
August 1, 2005;
289(2):
R605 - R612.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Yang and L. Bankir
Urea and urine concentrating ability: new insights from studies in mice
Am J Physiol Renal Physiol,
May 1, 2005;
288(5):
F881 - F896.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Lucien, P. Bruneval, F. Lasbennes, M.-F. Belair, C. Mandet, J.-P. Cartron, P. Bailly, and M.-M. Trinh-Trang-Tan
UT-B1 urea transporter is expressed along the urinary and gastrointestinal tracts of the mouse
Am J Physiol Regulatory Integrative Comp Physiol,
April 1, 2005;
288(4):
R1046 - R1056.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. P. Smith, E. A. Potter, R. A. Fenton, and G. S. Stewart
Characterization of a human colonic cDNA encoding a structurally novel urea transporter, hUT-A6
Am J Physiol Cell Physiol,
October 1, 2004;
287(4):
C1087 - C1093.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Inoue, S. D. Jackson, T. Vikulina, J. D. Klein, K. Tomita, and S. M. Bagnasco
Identification and characterization of a Kidd antigen/UT-B urea transporter expressed in human colon
Am J Physiol Cell Physiol,
July 1, 2004;
287(1):
C30 - C35.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. S. Stewart, R. A. Fenton, W. Wang, T.-H. Kwon, S. J. White, V. M. Collins, G. Cooper, S. Nielsen, and C. P. Smith
The basolateral expression of mUT-A3 in the mouse kidney
Am J Physiol Renal Physiol,
May 1, 2004;
286(5):
F979 - F987.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Zhang and A. Edwards
Theoretical effects of UTB urea transporters in the renal medullary microcirculation
Am J Physiol Renal Physiol,
October 1, 2003;
285(4):
F731 - F747.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Fenton, C.-L. Chou, S. Ageloff, W. Brandt, J. B. Stokes, and M. A. Knepper
Increased collecting duct urea transporter expression in Dahl salt-sensitive rats
Am J Physiol Renal Physiol,
July 1, 2003;
285(1):
F143 - F151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Sands
Urine-Concentrating Ability in the Aging Kidney
Sci. Aging Knowl. Environ.,
June 18, 2003;
2003(24):
pe15 - 15.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. M. Bagnasco
Gene structure of urea transporters
Am J Physiol Renal Physiol,
January 1, 2003;
284(1):
F3 - F10.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Sands
Molecular Approaches to Urea Transporters
J. Am. Soc. Nephrol.,
November 1, 2002;
13(11):
2795 - 2806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-M. Trinh-Trang-Tan, F. Lasbennes, P . Gane, N. Roudier, P. Ripoche, J.-P. Cartron, and P. Bailly
UT-B1 proteins in rat: tissue distribution and regulation by antidiuretic hormone in kidney
Am J Physiol Renal Physiol,
November 1, 2002;
283(5):
F912 - F922.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Lucien, F. Sidoux-Walter, N. Roudier, P. Ripoche, M. Huet, M.-M. Trinh-Trang-Tan, J.-P. Cartron, and P. Bailly
Antigenic and Functional Properties of the Human Red Blood Cell Urea Transporter hUT-B1
J. Biol. Chem.,
September 6, 2002;
277(37):
34101 - 34108.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Yang, L. Bankir, A. Gillespie, C. J. Epstein, and A. S. Verkman
Urea-selective Concentrating Defect in Transgenic Mice Lacking Urea Transporter UT-B
J. Biol. Chem.,
March 15, 2002;
277(12):
10633 - 10637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Lucien, J. Chiaroni, J.-P. Cartron, and P. Bailly
Partial deletion in the JK locus causing a Jknull phenotype
Blood,
February 1, 2002;
99(3):
1079 - 1081.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Mistry, S. Honda, T. Hirata, A. Kato, and S. Hirose
Eel urea transporter is localized to chloride cells and is salinity dependent
Am J Physiol Regulatory Integrative Comp Physiol,
November 1, 2001;
281(5):
R1594 - R1604.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. T. Timmer, J. D. Klein, S. M. Bagnasco, J. J. Doran, J. W. Verlander, R. B. Gunn, and J. M. Sands
Localization of the urea transporter UT-B protein in human and rat erythrocytes and tissues
Am J Physiol Cell Physiol,
October 1, 2001;
281(4):
C1318 - C1325.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Bagnasco, T. Peng, M. G. Janech, A. Karakashian, and J. M. Sands
Cloning and characterization of the human urea transporter UT-A1 and mapping of the human Slc14a2 gene
Am J Physiol Renal Physiol,
September 1, 2001;
281(3):
F400 - F406.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Fenton, A. Howorth, G. J. Cooper, R. Meccariello, I. D. Morris, and C. P. Smith
Molecular characterization of a novel UT-A urea transporter isoform (UT-A5) in testis
Am J Physiol Cell Physiol,
November 1, 2000;
279(5):
C1425 - C1431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. Sidoux-Walter, N. Lucien, R. Nissinen, P. Sistonen, S. Henry, J. Moulds, J.-P. Cartron, and P. Bailly
Molecular heterogeneity of the Jknull phenotype: expression analysis of the Jk(S291P) mutation found in Finns
Blood,
August 15, 2000;
96(4):
1566 - 1573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H. Saier Jr
Families of transmembrane transporters selective for amino acids and their derivatives
Microbiology,
August 1, 2000;
146(8):
1775 - 1795.
[Full Text]
|
 |
|

|
 |

|
 |
 
F. Sidoux-Walter, N. Lucien, B. Olives, R. Gobin, G. Rousselet, E.-J. Kamsteeg, P. Ripoche, P. M. T. Deen, J.-P. Cartron, and P. Bailly
At Physiological Expression Levels the Kidd Blood Group/Urea Transporter Protein Is Not a Water Channel
J. Biol. Chem.,
October 15, 1999;
274(42):
30228 - 30235.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. SANDS
Regulation of Renal Urea Transporters
J. Am. Soc. Nephrol.,
March 1, 1999;
10(3):
635 - 646.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
R. A. Fenton, G. J. Cooper, I. D. Morris, and C. P. Smith
Coordinated expression of UT-A and UT-B urea transporters in rat testis
Am J Physiol Cell Physiol,
June 1, 2002;
282(6):
C1492 - C1501.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1998 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|